The role of bile acids to ameliorate obesity driven triple negative breast cancer
胆汁酸在改善肥胖引起的三阴性乳腺癌中的作用
基本信息
- 批准号:10437599
- 负责人:
- 金额:$ 1.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-04 至 2022-08-15
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcidsAddressAffectAgonistAnastomosis - actionBile AcidsBile fluidBody WeightBody Weight decreasedBreast Cancer CellBreast Cancer ModelBreast Cancer Risk FactorBreast Cancer TreatmentCancer SurvivorCell ProliferationCellsClinicalCommon bile duct structureDataDependenceDietary InterventionDigestionFDA approvedFemaleFibroblastsGallbladderGoalsGrowthHumanImmuneImplantIn VitroInterventionLeadLigationLinkMalignant NeoplasmsMediatingMediator of activation proteinMentorsMetabolicMinority WomenModelingMolecularMusNeoplasm MetastasisObese MiceObesityOncogenicOperative Surgical ProceduresOutcomePathway interactionsPatientsPharmaceutical PreparationsPharmacological TreatmentPharmacologyPhosphotransferasesPre-Clinical ModelPremenopauseReceptor ActivationReceptor SignalingRecurrenceRelapseReportingRetrospective StudiesRiskRoleSecondary toSignal TransductionTestingTherapeuticThinnessTimeTrainingTransgenic MiceTreatment EfficacyTumor ImmunityTumor SuppressionTumor Suppressor ProteinsWeightaggressive breast cancerbariatric surgerybreast cancer progressioncancer cellcancer riskcancer subtypesclinically relevantdiet-induced obesityhigh riskileumimprovedin vivoinnovationloss of functionmalignant breast neoplasmmetabolic profilemigrationmolecular targeted therapiesmortalitymouse modelnovelnovel therapeuticspre-clinicalreceptorreceptor expressionrelapse predictionsham surgerytargeted treatmenttraining opportunitytreatment responsetriple-negative invasive breast carcinomatumortumor microenvironmenttumor progressionyoung woman
项目摘要
Triple negative breast cancer (TNBC) is an aggressive subtype, associated with obesity, that disproportionately
affects young and minority women; with no molecularly targeted therapies for this subtype, outcomes remain
very poor. Obesity induces immune and metabolic changes to the tumor microenvironment that lead to higher
risk of invasion, metastases, and recurrence, as well as poor response to therapy and higher mortality. Despite
known associations, the mechanistic interdependencies between obesity and breast cancer remain unclear.
Patients who underwent bariatric surgery had significantly reduced risk of breast cancer, including TNBC. My
premise is that underlying beneficial mechanisms uniquely associated with surgically induced weight loss can
be capitalized upon to mimic the benefits of surgery to reduce cancer risk. Therefore, the ultimate goal of this
proposal is to test novel pharmacologic treatments to improve TNBC outcomes informed by diet and surgical
interventions. A potential mediator of benefits after surgical weight loss is highly elevated circulating bile acids.
The bile acid receptor, farnesoid X receptor (FXR), mediated weight loss and metabolic benefits of bariatric
surgery. We present striking preliminary data for a role of FXR activation in reducing TNBC progression in vivo
with significant changes in immune cells suggesting improved anti-tumor immunity. We also demonstrate FXR
activation blunts proliferation, migration and invasion in human and murine TNBC cells in vitro. In patients, we
observed that FXR is a significant predictor of relapse-free survival in TNBC. Therefore, I hypothesize that
activating FXR, via elevated bile acids secondary to bariatric surgery or pharmacologically targeting FXR, will
improve TNBC outcomes. With my training and expertise of my mentoring team, I am well poised to rigorously
investigate underlying bile acidFXRTNBC mechanisms to determine therapeutic efficacy of FXR agonism.
Aim 1 will use a preclinical TNBC model to determine to what extent elevated bile acids abrogate obesity-
associated TNBC progression using an innovative bile diversion bariatric surgery. Aim 2 will determine if
pharmacologic FXR activation using an existing FDA-approved FXR agonist will improve therapeutic efficacy for
TNBC. Using loss of function models Aim 2 will determine the contribution of FXR in tumor intrinsic vs. extrinsic
anti-tumor immune-mediated mechanisms to reduce TNBC. Outcomes from this proposal will be high impact as
the first to test the dependence of TNBC on bile acids and FXR. A limited understanding of the mechanistic links
between breast cancer and obesity pose a fundamental obstacle to helping patients. Since obesity rates are
rising, completion of this project will ultimately address an urgent unmet clinical need in TNBC treatment as well
as provide an exceptional F32 training opportunity.
三阴性乳腺癌(TNBC)是一种侵袭性亚型,与肥胖相关,不成比例地
影响年轻和少数族裔妇女;由于没有针对这一亚型的分子靶向治疗,结果仍然存在
非常穷。肥胖导致肿瘤微环境的免疫和代谢变化,从而导致
侵袭、转移和复发的风险,以及对治疗反应差和较高的死亡率。尽管
已知的关联,肥胖和乳腺癌之间的机械性相互依存关系仍不清楚。
接受减肥手术的患者患乳腺癌的风险显著降低,包括TNBC。我的
前提是唯一与手术诱导的减肥相关的潜在有益机制可以
被利用来模仿手术的好处,以降低癌症风险。因此,这样做的最终目的是
建议测试新的药物治疗方法,以改善通过饮食和手术获得的TNBC结果
干预措施。手术后体重减轻的一个潜在的中介因素是循环胆汁酸的高度升高。
胆汁酸受体法尼醇X受体(FXR)介导的减肥和代谢益处
做手术。我们提供了引人注目的初步数据,表明FXR激活在体内抑制TNBC进展中的作用
免疫细胞的显著变化表明抗肿瘤免疫能力有所提高。我们还演示了FXR
激活抑制体外培养的人和小鼠TNBC细胞的增殖、迁移和侵袭。在病人身上,我们
观察到FXR是TNBC无复发生存率的重要预测因子。因此,我假设
通过减肥手术后继发的胆汁酸升高或药物靶向FXR激活FXR,将
改善TNBC结果。凭借我的培训和我的指导团队的专业知识,我已经准备好严格地
研究潜在的胆汁酸,FXR,,TNBC机制,以确定FXR激动剂的治疗效果。
目标1将使用临床前TNBC模型来确定胆汁酸升高在多大程度上消除肥胖-
使用创新的胆汁分流减肥手术的相关TNBC进展。目标2将决定是否
使用FDA批准的现有FXR激动剂的药理学FXR激活将提高对
TNBC。使用功能丧失模型Aim 2将确定FXR在肿瘤内在与外在中的作用
抗肿瘤免疫介导的降低TNBC的机制。这项提案的结果将产生很大影响,因为
首次测试了TNBC对胆汁酸和FXR的依赖性。对机械连杆的有限理解
乳腺癌和肥胖症之间的关系是帮助患者的根本障碍。因为肥胖率是
随着这个项目的完成,最终也将解决TNBC治疗中未得到满足的迫切临床需求
AS提供了一个特殊的F32培训机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura Marie Sipe其他文献
Laura Marie Sipe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura Marie Sipe', 18)}}的其他基金
The role of bile acids to ameliorate obesity driven triple negative breast cancer
胆汁酸在改善肥胖引起的三阴性乳腺癌中的作用
- 批准号:
10154863 - 财政年份:2021
- 资助金额:
$ 1.08万 - 项目类别:
相似国自然基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
- 批准号:22007039
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
- 批准号:
- 批准年份:2019
- 资助金额:10.0 万元
- 项目类别:省市级项目
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
- 批准号:21372217
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
- 批准号:21172061
- 批准年份:2011
- 资助金额:30.0 万元
- 项目类别:面上项目
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
- 批准号:21176225
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
- 批准号:81072511
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
- 批准号:30660215
- 批准年份:2006
- 资助金额:21.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Lipid nanoparticle-mediated Inhalation delivery of anti-viral nucleic acids
脂质纳米颗粒介导的抗病毒核酸的吸入递送
- 批准号:
502577 - 财政年份:2024
- 资助金额:
$ 1.08万 - 项目类别:
CAREER: Highly Rapid and Sensitive Nanomechanoelectrical Detection of Nucleic Acids
职业:高度快速、灵敏的核酸纳米机电检测
- 批准号:
2338857 - 财政年份:2024
- 资助金额:
$ 1.08万 - 项目类别:
Continuing Grant
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 1.08万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 1.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Synthetic analogues based on metabolites of omega-3 fatty acids protect mitochondria in aging hearts
基于 omega-3 脂肪酸代谢物的合成类似物可保护衰老心脏中的线粒体
- 批准号:
477891 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Operating Grants
Metabolomic profiles of responders and non-responders to an omega-3 fatty acids supplementation.
对 omega-3 脂肪酸补充剂有反应和无反应者的代谢组学特征。
- 批准号:
495594 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated understanding and manipulation of hypoxic cellular functions by artificial nucleic acids with hypoxia-accumulating properties
具有缺氧累积特性的人工核酸对缺氧细胞功能的综合理解和操纵
- 批准号:
23H02086 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 1.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)